Original Research

Lactate Dehydrogenase to Albumin Ratio As Prognostic Biomarker in Sepsis: A Retrospective Study

DOI https://doi.org/10.70302/jpsim.v7i4.2667
Received: 20 Oct 2026 Accepted: 20 Nov 2026 Published Online: 20 Nov 2026

Abstract

Objective:

To evaluate the prognostic value of the lactate dehydrogenase to albumin ratio in predicting the outcomes of patients admitted with sepsis.

Methodology:

This retrospective cohort study was conducted in the medical units of Mayo Hospital. Records of 168 patients admitted with sepsis from March 2022 to March 2023 were obtained after permission from the ethical review board. Lactate dehydrogenase to albumin ratio was calculated from the investigations done at the time of admission. Outcome of patients was noted. Multivariable regression and receiver operating characteristics curve analysis was carried out to determine usefulness of this ratio. Categorical variables were expressed in percentages and continuous variables by median (interquartile range).

Results:

Out of 168 patients 104 (61.9%) were males and 64 (38.1%) were females with a mean age of 55 years [interquartile range=38-66 years]. One hundred and seven patients (63.6%) were discharged and the remaining expired. All-cause mortality was higher in patients with high lactate dehydrogenase to albumin ratio (p value <0.001). Area under the receiver operator curve was 0.735 [95% CI=0.659-0.810]. Cut off value of 191.2 calculated from the receiver operator curve was found to have sensitivity of 70.58% and specificity of 37.4% as mortality predictor.

Conclusion:

Lactate dehydrogenase to albumin ratio can be used as a predictive biomarker of mortality in patients admitted with sepsis.

Keywords:
Lactate dehydrogenase serum albumin sepsis infection

How to Cite This Article

Suhail A, Bangash AF, Suhail M, Tahir I, Butt NF. Lactate Dehydrogenase to Albumin Ratio As Prognostic Biomarker in Sepsis: A Retrospective Study. J Pak Soc Intern Med. 2026;7(4):337–344. doi:10.70302/jpsim.v7i4.2667

⭳ Download XML (JATS) ⭳ Download PDF

Conflict of Interest

The authors declare no conflict of interest.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

This research received no specific grant from any funding agency.

Funder information follows the Crossref Funder Registry standard.

Author Contributions

AS: Conception.
AFB, MS: Design of the work.
IT, NFB: Data acquisition, analysis, or interpretation.
AFB, MS, IT: Draft the work.
AS, NFB: Review critically for important intellectual content.
All authors approve the version to be published.
All authors agree to be accountable for all aspects of the work.

Contributions are recorded against the ICMJE criteria for authorship.

Data Availability

Data are available from the corresponding author on reasonable request.

Ethics Statement

This study was approved by King Edward Medical University. Approval number: 791/RC/KEMU.

Conducted in accordance with the Declaration of Helsinki.

References

  1. Gavelli F, Castello LM, Avanzi GC. Management of sepsis and septic shock in the emergency department. Intern Emerg Med. 2021;16(6):1649–61.
  2. Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019; doi:10.1177/2050312119835043 doi:10.1177/2050312119835043
  3. Jeon SY, Ryu S, Oh SK, Park JS, You YH, Jeong WJ, et al. Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care. Medicine (Baltimore). 2021;100(6):e27538.
  4. Santacroce E, D’Angerio M, Ciobanu AL, Masini L, Lo Tartaro D, Coloretti I, et al. Advances and challenges in sepsis management: Modern tools and future directions. Cells. 2024;13(2):439.
  5. Pant A, Mackraj I, Govender T. Advances in sepsis diagnosis and management: A paradigm shift towards nanotechnology. J Biomed Sci. 2021;28(1):60.
  6. Mohamed AKS, Mehta AA, James P. Predictors of mortality of severe sepsis among adult patients in the medical intensive care unit. Lung India. 2017;34(4):330–5.
  7. Ramdeen S, Ferrell B, Bonk C, Schubel L, Littlejohn R, Capan M, et al. The available criteria for different sepsis scoring systems in the emergency. Open Access Emerg Med. 2021;doi: 10.2147/OAEM.S280279 doi:10.2147/OAEM.S280279
  8. Pierrakos C, Vincent J-L. Sepsis biomarkers: A review. Crit Care. 2010;14(1):R15.
  9. Liu J, Bai C, Li B, Shan A, Shi F, Yao C, et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021;https://doi.org/10.1038/s41598-020-79843-5 doi:10.1038/s41598-020-79843-5
  10. Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: Time for a reappraisal. Crit Care. 2020;doi:10.1186/s13054-020-02993-5 doi:10.1186/s13054-020-02993-5
  11. 12. Lu J, Wei Z, Jiang H, Cheng L, Chen Q, Chen M, et al. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: A retrospective observational study. J Surg Res. 2018;doi:10.1016/j.jss.2018.03.035 doi:10.1016/j.jss.2018.03.035
  12. Yin M, Si L, Qin W, Li C, Zhang J, Yang H, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: A prospective cohort study. J Intensive Care Med. 2018;33(10):687–94.
  13. Arnau-Barrés I, Güerri-Fernández R, Luque S, Sorli L, Vázquez O, Miralles R. Serum albumin is a strong predictor of sepsis outcome in elderly patients. Eur J Clin Microbiol Infect Dis. 2019;38(4):743–6.
  14. Wang J, Fei W, Song Q. One-year mortality prediction for patients with sepsis: A nomogram integrating lactic dehydrogenase and clinical characteristics. BMC Infect Dis. 2023;doi: 10.1186/s12879-023-08636-8 doi:10.1186/s12879-023-08636-8
  15. Fang Y, Zhang Y, Zhang X. The elevated lactate dehydrogenase to albumin ratio is a risk factor for developing sepsis-associated acute kidney injury: A single-center retrospective study. BMC Nephrol. 2024;https://doi.org/10.1186/s12882-024-03636-5 doi:10.1186/s12882-024-03636-5
  16. Gharipour A, Razavi R, Gharipour M, Mukasa D. Lactate/albumin ratio: An early prognostic marker in critically ill patients. Am J Emerg Med. 2020;38(10):2088–95.10.
  17. Marik PE, Taeb AM. SIRS, qSOFA and new sepsis definition. J Thorac Dis. 2017;9(4):943–5.
  18. Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O’Brien C, et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open. 2019;2(2):e187571.
  19. Alizadeh N, Tabatabaei FS, Azimi A, Faraji N, Akbarpour S, Dianatkhah M, et al. Lactate dehydrogenase to albumin ratio as a predictive factor of covid-19 patients’ outcome; a cross-sectional study. Archives of Academic Emergency Medicine 2022; 10. doi: 10.22037/aaem.v10i1.1646 doi:10.22037/aaem.v10i1.1646
  20. Cerceo E, Rachoin JS, Gaughan J, Weisberg L. Association of gender, age, and race on renal outcomes and mortality in patients with severe sepsis and septic shock. J Crit Care. 2021;doi: 10.1016/j.jcrc.2020.10.007. doi:10.1016/j.jcrc.2020.10.007
  21. Bou Chebl R, Tamim H, Abou Dagher G, Sadat M, Ghamdi G, Itani A, et al. Sepsis in end-stage renal disease patients: Are they at an increased risk of mortality? Ann Med. 2021;53(1):1737-43.
  22. Lin S, Ge S, He W, Zeng M. Association between comorbid diabetes mellitus and prognosis of patients with sepsis in the intensive care unit: A retrospective cohort study. Ann Transl Med. 2021;9(22):1699.
  23. Peters-Sengers H, Butler JM, Uhel F, Schultz MJ, Bonten MJ, Cremer OL, et al. Source-specific host response and outcomes in critically ill patients with sepsis: A prospective cohort study. Intensive Care Med. 2022;48(1):92–102.
  24. Dias A, Gomez V, Viola L, Rodrigues A, Weber S, Tartaro L. Fever is associated with earlier antibiotic onset and reduced mortality in patients with sepsis admitted to the ICU. Sci Rep. 2021;Doi: 10.1038/s41598-021-03296-7. doi:10.1038/s41598-021-03296-7

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2026 The Author(s).